2-(dimethylamino)ethyl methacrylate has been researched along with paclitaxel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auguste, DT; You, JO | 1 |
| Geckeler, KE; Lee, Y | 1 |
| Ding, Y; Ji, T; Li, Y; Nie, G; Su, S; Tian, Y; Wu, M; Wu, Y | 1 |
3 other study(ies) available for 2-(dimethylamino)ethyl methacrylate and paclitaxel
| Article | Year |
|---|---|
Feedback-regulated paclitaxel delivery based on poly(N,N-dimethylaminoethyl methacrylate-co-2-hydroxyethyl methacrylate) nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Delayed-Action Preparations; Diffusion; Drug Carriers; HeLa Cells; Humans; Materials Testing; Methacrylates; Nanoparticles; Paclitaxel; Particle Size | 2008 |
Cellular interactions of a water-soluble supramolecular polymer complex of carbon nanotubes with human epithelial colorectal adenocarcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Buffers; Caco-2 Cells; Cell Survival; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Electric Impedance; Humans; Methacrylates; Microscopy, Electron, Scanning; Nanotubes, Carbon; Paclitaxel; Polymerization; Rhodamine 123; Solubility; Water | 2012 |
"Triple-punch" strategy for triple negative breast cancer therapy with minimized drug dosage and improved antitumor efficacy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Endocytosis; Female; Humans; Indocyanine Green; Inhibitor of Apoptosis Proteins; Intracellular Space; Lactic Acid; Methacrylates; Mice; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Paclitaxel; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RNA, Small Interfering; Survivin; Triple Negative Breast Neoplasms | 2015 |